Moderna Says December COVID Vaccine Is Possible: 2 Stocks That Could Skyrocket

If a vaccine comes soon, it won’t just bring hope to the people who are learning to live with the pandemic. It will also dissipate the fear that’s crushing the market and the industries.

| More on:
healthcare pharma

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The first wave of the pandemic was enough to shake the world to its core, decimated whole economies and laying waste to industries and the job market. And even though most people knew that the first wave wasn’t the end of it, and we might have to live through multiple waves of the pandemic, it doesn’t make the second wave any less of a force.

Our defenses and measures are woefully incomplete without a proper vaccine. But the good news is that the vaccine might not be as far away as medical experts first predicted. U.S.-based Moderna, a biotech company, is very close to a working vaccine, and the CEO says if their clinical trials go well, they would be able to mass-produce and distribute the vaccine by the end of November.

If Moderna’s timeline is correct, and another vaccine comes from Pfizer around the same time, it can boost morale and dissipate fear among the population, giving the economy and the stock market strong new legs to stand upon. Several stocks might benefit from a vaccine, but there are two that might skyrocket once the vaccine is available.

A food group company

Restaurants and food businesses, especially ones that rely upon the foot traffic, have suffered terribly during the pandemic. MTY Food Group (TSX:MTY) is one of the companies that saw their stock take a dive down the cliff. In March, the stock price fell about 73% from its pre-pandemic high. That’s about three-fourth of the valuation gone in two months.

Despite the fact that the business took a serious hit, the stock did manage to recover a bit and grew about 163%. Though it’s still far below its pre-pandemic valuation, the stock is on its way up there. And a vaccine could expedite the pace exponentially. The company’s franchises and locations might start seeing foot traffic increase, and sales go up once the fear of the virus is gone.

A gaming company

The Great Canadian Gaming (TSX:GC) is an entertainment and hospitality company with a lot of physical locations like Casinos and race tracks to its name. If it were a computer gaming company or purely an online entertainment company, the pandemic would have been a boon for business. But since it also relies on foot traffic and people visiting its locations, the company’s stock suffered when the pandemic hit.

The share price dropped about 58%, and after a meager recovery, it’s still trading at a price that’s 45% lower than its pre-pandemic value. Unlike MTY, this stock is well poised for recovery-driven growth. And if a vaccine nudges people towards entertainment that this company is providing, after being cooped up in their homes because of lockdowns, the sales and stock could skyrocket.

Foolish takeaway

One danger associated with either stock, especially the great Canadian Gaming Company, is that the market crash might arrive before the vaccine. That might crush the nascent recovery both companies have seen in the last few months and may lessen its chances of recovery and growth. But if the vaccine comes first, it can create a powerful and positive investor sentiment around the company.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends MTY Food Group.

More on Dividend Stocks

growing plant shoots on stacked coins
Dividend Stocks

5 Dividend Stocks to Buy With Yields Upwards of 5%

These five companies all earn tonnes of cash flow, making them some of the best long-term dividend stocks you can…

Read more »

funds, money, nest egg
Dividend Stocks

TFSA Investors: 3 Stocks to Start Building an Influx of Passive Income

A TFSA is the ideal registered account for passive income, as it doesn't weigh down your tax bill, and any…

Read more »

A red umbrella stands higher than a crowd of black umbrellas.
Dividend Stocks

3 of the Safest Dividend Stocks in Canada

Royal Bank of Canada stock is one of the safest TSX dividend stocks to buy. So is CT REIT and…

Read more »

Growing plant shoots on coins
Dividend Stocks

1 of the Top Canadian Growth Stocks to Buy in February 2023

Many top Canadian growth stocks represent strong underlying businesses, healthy financials, and organic growth opportunities.

Read more »

stock research, analyze data
Dividend Stocks

Wherever the Market Goes, I’m Buying These 3 TSX Stocks

Here are three TSX stocks that could outperform irrespective of the market direction.

Read more »

woman data analyze
Dividend Stocks

1 Oversold Dividend Stock (Yielding 6.5%) to Buy This Month

Here's why SmartCentres REIT (TSX:SRU.UN) is one top dividend stock that long-term investors should consider in this current market.

Read more »

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Dividend Stocks

Better TFSA Buy: Enbridge Stock or Bank of Nova Scotia

Enbridge and Bank of Nova Scotia offer high yields for TFSA investors seeking passive income. Is one stock now undervalued?

Read more »

Golden crown on a red velvet background
Dividend Stocks

2 Top Stocks Just Became Canadian Dividend Aristocrats

These two top Canadian Dividend Aristocrats stocks are reliable companies with impressive long-term growth potential.

Read more »